Prognostic value of baseline modified barium swallow for perioperative dysphagia in oropharyngeal cancer: Secondary analysis of ECOG-ACRIN E3311

Unresolved referenced work

Kept as external metadata until matched

Human Papillomavirus and rising Oropharyngeal Cancer Incidence in the United States

10.1200/jco.22.02625 · 2023

Updated estimates of patients with Oropharyngeal Cancer in the US

10.1001/jamanetworkopen.2025.39258 · 2025

Aspiration pneumonia after chemo-intensity-modulated radiation therapy of oropharyngeal carcinoma and its clinical and dysphagia-related predictors

10.1002/hed.23275 · 2014

Association between severity of dysphagia and survival in patients with head and neck cancer

10.1002/hed.21819 · 2012

Aspiration pneumonia after concurrent chemoradiotherapy for head and neck cancer

10.1002/cncr.29207 · 2015

Phase II Randomized Trial of Transoral Surgery and Low-Dose Intensity Modulated Radiation Therapy in Resectable p16+ locally Advanced Oropharynx Cancer: an ECOG-ACRIN Cancer Research Group Trial (E3311)

10.1200/jco.21.01752 · 2022

Long-Term Follow-up of E3311, an ECOG-ACRIN Cancer Research Group phase II Trial of Transoral Surgery and Risk-based Adjuvant Treatment in Human Papillomavirus-Initiated Oropharynx Cancer

10.1200/jco-24-02550 · 2025

PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer

10.1186/s12885-015-1598-x · 2015

Long-term Functional and Quality-of-Life Outcomes after Transoral Robotic Surgery in patients with Oropharyngeal Cancer

2018

A prospective evaluation of short-term dysphagia after transoral robotic surgery for squamous cell carcinoma of the oropharynx

10.1002/cncr.30712 · 2017

Functional outcomes after TORS for oropharyngeal cancer: a systematic review

2015

Dysphagia after Primary Transoral Robotic Surgery with Neck Dissection vs Nonsurgical Therapy in patients with Low- to Intermediate-Risk Oropharyngeal Cancer. JAMA Otolaryngol-

2019

Functional Impact of Transoral Surgery and Risk-based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes from ECOG-ACRIN E3311

2025

Characterizing postoperative physiologic swallow function following transoral robotic surgery for early stage tonsil, base of tongue, and unknown primary human papillomavirus-associated squamous cell carcinoma

10.1002/hed.26632 · 2021

Early Adoption of Transoral Robotic Surgical Program: Preliminary Outcomes

10.1177/0194599812443353 · 2012

Functional outcomes after transoral robotic surgery for head and neck cancer

10.1016/j.otohns.2009.05.014 · 2009

Morbidity and mortality revue of the French group of transoral robotic surgery: a multicentric study

10.1007/s11701-015-0542-z · 2016

Analysis of readmissions after transoral robotic surgery for oropharyngeal squamous cell carcinoma

10.1002/hed.25362 · 2018

National Trends in 30-Day Readmission following Transoral Robotic Surgery for Oropharyngeal Squamous Cell Carcinoma. JAMA Otolaryngol-

2024

Identification of Clinical and Socioeconomic Predictors of Adjuvant Therapy after Trans-Oral Robotic Surgery in patients with Oropharyngeal Squamous Cell Carcinoma

10.3390/cancers12092474 · 2020

Predictors of weight loss during and after radiotherapy in patients with head and neck cancer: a longitudinal study

10.1016/j.ejon.2019.02.004 · 2019

Baseline health perceptions, dysphagia, and survival in patients with head and neck cancer

10.1002/cncr.28482 · 2014

Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes

10.1097/phm.0b013e31829b4afe · 2013

PRO-ACTIVE: results of a pragmatic phase IV randomized trial comparing the effectiveness of prophylactic swallow intervention for patients receiving radiotherapy for head and neck cancer

2025

The PRO-ACTIVE trial protocol: a randomized study comparing the effectiveness of PROphylACTic swallow InterVEntion for patients receiving radiotherapy for head and neck cancer

10.1186/s12885-021-08826-0 · 2021

Baseline swallowing measures predict recovery at 6 weeks after transoral robotic surgery for head and neck cancer

2017

Dynamic Imaging Grade of Swallowing Toxicity (DIGEST): Scale development and validation

10.1002/cncr.30283 · 2017

Refining measurement of swallowing safety in the Dynamic Imaging Grade of Swallowing Toxicity (DIGEST) criteria: Validation of DIGEST version 2

10.1002/cncr.34079 · 2022

10.1002/(sici)1097-0142(19960601)77:113.0.co;2-s

10.1002/(sici)1097-0142(19960601)77:11<2294::aid-cncr17>3.0.co;2-s

The development and validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer: the M. D. Anderson dysphagia inventory

2001

Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module

10.1002/hed.20602 · 2007

Radiotherapy dose-volume parameters predict videofluoroscopy-detected dysphagia per DIGEST after IMRT for oropharyngeal cancer: results of a prospective registry

10.1016/j.radonc.2018.06.013 · 2018

Novel strategies to Effectively De-escalate Curative-intent Therapy for patients with HPV-Associated Oropharyngeal Cancer: current and Future Directions

10.1200/edbk_280687 · 2020

Current evidence of a Deintensification Strategy for patients with HPV-Related Oropharyngeal Cancer

10.3390/cancers14163969 · 2022

National treatment trends in human papillomavirus–positive oropharyngeal squamous cell carcinoma

10.1002/cncr.32654 · 2020

De-escalated adjuvant radiotherapy versus standard adjuvant treatment for human papillomavirus-associated oropharyngeal squamous cell carcinoma (MC1675): a phase 3, open-label, randomised controlled trial

10.1016/s1470-2045(25)00324-9 · 2025

Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial

10.1016/s0140-6736(18)32779-x · 2019

Dysphagia-optimised intensity-modulated radiotherapy versus standard intensity-modulated radiotherapy in patients with head and neck cancer (DARS): a phase 3, multicentre, randomised, controlled trial

10.1016/s1470-2045(23)00265-6 · 2023

Radiotherapy versus transoral robotic surgery and neck dissection for oropharyngeal squamous cell carcinoma (ORATOR): an open-label, phase 2, randomised trial

10.1016/s1470-2045(19)30410-3 · 2019

Reply to: Building on ECOG-ACRIN E3311 to Strengthen Interpretation of Swallowing Outcomes

10.1200/oa-26-00024 · doi-reference

Long-Term, prospective Performance of the MD Anderson Dysphagia Inventory in “Low-Intermediate Risk” Oropharyngeal Carcinoma after Intensity Modulated Radiation Therapy

10.1016/j.ijrobp.2016.06.010 · doi-reference

Individual patient-reported symptom items discriminate imaging-graded dysphagia in head and neck cancer patients treated with radiotherapy: secondary analysis of pooled prospective studies

10.1016/j.radonc.2026.111365 · doi-reference

Dysphagia Treatment for patients with Head and Neck Cancer Undergoing Radiation Therapy: a Meta-analysis Review

10.1016/j.ijrobp.2018.01.097 · doi-reference

Prophylactic Swallowing Therapy during Head-and-Neck Cancer Radiotherapy: effect of Service-delivery Mode and overall Adherence Level on Swallowing Function and Muscle Strength—the PRESTO Trial

10.1007/s00455-023-10609-7 · doi-reference

Transoral Robotic Surgery in the Multidisciplinary Care of Patients with Oropharyngeal Squamous Cell Carcinoma: ASCO Guideline

10.1200/jco-24-02755 · doi-reference

Short- and Long-Term Swallowing Outcomes in Head and Neck Cancer patients Receiving TORS and Adjuvant Therapy

10.1002/hed.28033 · doi-reference

Transoral Laser or Robotic Surgery Outcomes for Oropharyngeal Carcinoma: Secondary Analysis of the PATHOS Randomized Clinical Trial

10.1001/jamaoto.2024.3371 · doi-reference